AML, Breast Cancer anti-cancer synergy - check!
CCRCC - yes positive indication but small sample because scoping study - so confirm to proceed, need a good model.
You might have missed the good news in the quarterly - god only knows why they chose to hide it!?
Breast Cancer anti-cancer synergy is worth what again - oh that's right $8Bn to $15Bn per annum in an existing, active market where the surveyed oncologists said "there's no reason I wouldn't prescribe it every time I prescribe doxo"* and "I'll probably prescribe doxo with Zantrene more than I do now"* (which increases the $8Bn to $15Bn per year to bigger numbers!
You might be right about sentiment though, because Race isn't engendering enthusiasm and it seems that people can't comprehend the information that's in there.
*paraphrasing from the Triangle presentation but pretty decent reflection of my interpretation of what they said
AML, Breast Cancer anti-cancer synergy - check!CCRCC - yes...
-
- There are more pages in this discussion • 6,439 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
0.040(2.86%) |
Mkt cap ! $245.3M | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.49 | $1.41 | $101.7K | 69.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9216 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 7767 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |